Form 4: Orthopediatrics Director Samuel Riccitelli Boosts Stake with Significant Stock Award

Orthopediatrics Corp. Director Samuel D. Riccitelli has increased his beneficial ownership in the company by acquiring 8,401 shares of common stock through a restricted stock award on May 23, 2025.

Summary

• Samuel D. Riccitelli, a Director of Orthopediatrics Corp. (KIDS), acquired 8,401 shares of common stock on May 23, 2025.
• The acquisition was made at a price of $0 per share, indicating it was a grant or award, specifically noted as part of restricted stock awards.
• Following this transaction, Mr. Riccitelli's direct beneficial ownership in Orthopediatrics Corp. stands at 20,423 shares of common stock.
• His total beneficial ownership includes 10,900 shares of restricted stock awards.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if a grant, generally indicates alignment of interests and confidence in the company's future, contributing to a moderately positive sentiment. The $0 price indicates it's a grant, not a cash purchase, which slightly tempers the positive signal compared to an open market buy.

Positives

• An increase in a director's beneficial ownership, even through a grant, can signal continued alignment of interests with shareholders and confidence in the company's future.
• The grant of restricted stock awards to a director is a common form of executive compensation, aligning long-term incentives.

Negatives

• The acquisition was at a price of $0, indicating it was a grant rather than an open market purchase, which might be perceived as less of a direct financial commitment compared to a cash purchase.

Future Outlook

NA

Industry Context

This transaction is a routine insider filing, common across all industries, reflecting compensation practices and insider holdings rather than specific industry trends.

Related Party Transactions

• The acquisition of 8,401 shares by Director Samuel D. Riccitelli is considered a related party transaction as it involves an insider of the company.

Stakeholder Impact

• Shareholders: The increase in a director's beneficial ownership, even through a grant, can be viewed positively as it aligns management's interests with shareholder value. It may signal confidence in the company's long-term prospects.

Key Dates

Recommendation

Keywords

Orthopediatrics Corp., KIDS, Samuel D. Riccitelli, Director, SEC Form 4, Insider Transaction, Stock Award, Restricted Stock, Beneficial Ownership, Equity Compensation